Status:
public
Videos: (
0
) Documents: (
0
) Comments: (
0
)
Group description
Group Videos
No videos have been added jet. You may join this group and add yours now.
Group Documents
No documents have been added jet. You may join this group and add yours now.
News
- Skin and Joint Care for Psoriatic Arthritis
When you have psoriatic arthritis, you have to cope with painful joints and frustrating skin flares. Here are treatment and self-care tips for both. - Coping With Psoriatic Arthritis
Cope with the emotional and physical demands of psoriatic arthritis with these management tips. - Psoriatic Arthritis - New Drug Offers Relief
Around 7.5 million Americans, which is about 2.2% of the population, suffer from psoriaris, an autoimmune disease causing red, flaky skin. A new review in the Journal of the American Academy of Orthopedic Surgeons (JAAOS) reveals that patients with psoriatic arthritis (PsA), a type of arthritis that affects nearly 48% of patients with the skin disease psoriasis, gain substantial benefits from ... - Anacor Pharmaceuticals Announces Positive Preliminary Results from Two Safety Studies of AN2728 and Updates Atopic ...
Anacor Pharmaceuticals announced today positive preliminary results from two safety studies of AN2728 - a maximal use systemic exposure study in psoriatic patients and a local tolerability study. - New medication, surgery may offer relief for patients with psoriatic arthritis
( American Academy of Orthopaedic Surgeons ) Medications or biologic agents that target T-cells, white blood cells involved in the body's immune system, appear to offer significant benefit to patients suffering from psoriatic arthritis, a type of arthritis that affects up to 48 percent of patients with the skin disease psoriasis, according to a new review article in the Journal of the American ... - Press Release
Anacor Pharmaceuticals (NASDAQ:ANAC) announced today positive preliminary results from two safety studies of AN2728 - a maximal use systemic exposure (MUSE) study in psoriatic patients and a local tolerability study. - Research and Markets: Thought Leader Insight & Analysis Report - Psoriasis Q4 2011
Research and Markets has announced the addition of the "Thought Leader Insight & Analysis Report - Psorias - Research and Markets: Thought Leader Insight & Analysis Report - Psoriasis Q2 2011
Research and Markets has announced the addition of the "Thought Leader Insight & Analysis Report - Psorias - Anacor Reports Positive Preliminary Results From Two Safety Studies Of AN2728
Anacor Reports Positive Preliminary Results From Two Safety Studies Of AN2728 - Patients with PsA may benefit from new medications and surgeries
Medications or biologic agents that target T-cells, white blood cells involved in the body's immune system, appear to offer significant benefit to patients suffering from psoriatic arthritis (PsA), a type of arthritis that affects up to 48 percent of patients with the skin disease psoriasis, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons.